Trials / Unknown
UnknownNCT02890186
Dual-loop Target Controlled Infusion for Coadministration of Propofol and Remifentanil Guided by Narcotrend Index
Dual-loop Target Controlled Infusion for Coadministration of Propofol and Remifentanil Guided by Narcotrend Index in Anterior Cervical Decompression and Fusion With Internal Fixation
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Guangzhou General Hospital of Guangzhou Military Command · Academic / Other
- Sex
- All
- Age
- 23 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To investigate the application of closed target-controlled infusion(TCI) of propofol and remifentanil guided by Narcotrend index in the anterior cervical decompression and fusion with internal fixation surgery.
Detailed description
Sixty patients scheduled for anterior cervical decompression and fusion with internal fixation surgery under general anesthesia were randomly divided into two groups:closed-loop (group A,n=30) and open-loop group(group B,n=30).The procedure during induction of anesthesia was same in two groups.In group A,if Narcotrend index(NI) fall down to 46 and keep more than 30 seconds,propofol and remifentanil were intravenously infused as feedback automatically to achieve the target NI of 26-46.However,the NI in group B was controlled manually.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Narcotrend | the investigator modified the effect-site target concentrations by NI.If NI fall down to 46 and keep 46 more than 30 seconds,propofol and remifentanil were infused as feedback automatically to achieve the target NI of 26-46. |
| OTHER | experience | the investigator modified the effect-site target concentrations of both drugs without minimum or maximum concentration limits without using the Narcotrend monitor only depend on the experience of anesthesiologist. |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2016-09-07
- Last updated
- 2016-09-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02890186. Inclusion in this directory is not an endorsement.